Estadístiques de Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria

Visites totals

views
Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria 171

Visites totals per mes

views
July 2024 0
August 2024 6
September 2024 4
October 2024 0
November 2024 1
December 2024 0
January 2025 0

Visites al fitxer

views
curto-bjd-omal.pdf(legacy) 350
curto-bjd-omal.pdf 4

Vistes principals per país

views
United States 113
Spain 22
Germany 15
France 3
United Kingdom 3
Belgium 2
Switzerland 2
China 2
Japan 2
Sweden 2
Ukraine 2
Canada 1
Czechia 1
Denmark 1

Visites principals per ciutat

views
Ashburn 23
San Ramon 17
Fairfield 14
Barcelona 9
Cambridge 5
Mountain View 5
Menlo Park 4
Seattle 4
New York 3
San Diego 3
Tustin 3
Boardman 2
Frankfurt Am Main 2
Madrid 2
Shenzhen 2
Altadena 1
Basel 1
Brooklyn 1
Copenhagen 1
Coslada 1
Falls Church 1
Gatineau 1
Hamburg 1
Jacksonville 1
Magdeburg 1
Premiá De Mar 1
Redwood City 1
Rochester 1
Sacramento 1
Saint Albans 1
Salamanca 1
Santa Perpetua 1
Tokyo 1
Trazo 1